Identification of a non peptidic RANTES antagonist

Bioorganic and Medicinal Chemistry Letters

Volumn 8, Issue 7, 1998, Pages 771-774

  Bright, Colin ^a   Brown, Thomas J ^a   Cox, Paul ^a   Halley, Frank ^a   Lockey, Peter ^a   McLay, Iain M ^a   Moore, Una ^a   Porter, Barry ^a   Williams, Robert J ^a  

^a SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; MONOCYTE CHEMOTACTIC PROTEIN 1; PHENOTHIAZINE DERIVATIVE; RANTES; RP 23618; UNCLASSIFIED DRUG;

ARTICLE; CELL MEMBRANE; CHEMICAL MODIFICATION; CHEMOTAXIS; DRUG SYNTHESIS; HELPER CELL; HUMAN; HUMAN CELL; PROTEIN BINDING;

CELL MEMBRANE; CHEMOKINE CCL2; DRUG DESIGN; HUMANS; INDICATORS AND REAGENTS; IODINE RADIOISOTOPES; KINETICS; MOLECULAR STRUCTURE; PHENOTHIAZINES; RANTES; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 0032492657     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(98)00094-8     Document Type: Article

References (18)

1. 1. Zhang, L; Redington, A.E.; Holgate, S.T. Clin. Exp. allergy, 1994, 24, 899-904 and references cited. Baggiolini, M.; Dewald, B.; Moser, B. Annu. Rev. Immunol. 1997, 15, 675-705.
2. 1. Zhang, L; Redington, A.E.; Holgate, S.T. Clin. Exp. allergy, 1994, 24, 899-904 and references cited. Baggiolini, M.; Dewald, B.; Moser, B. Annu. Rev. Immunol. 1997, 15, 675-705.
3. 2. Taub D.; Conlon, K.; Lloyd, A.R.; Oppenheim, J.J.; Kelvin, D.J. Science, 1993, 260, 355-358.
4. 3. Schall, T.J; Bacon, K.; Yoy K.J.; Goeddel D.V. Nature, 1990, 347, 669-71.
5. 4. Wang, J-M.; McVicar, D.W.; Oppenheim, J.J.; Kelvin, D.J. J. Exp. Med. 1993, 177, 699-705.
6. 5. Kameyoshi, Y.; Döerschner, A.; Mallet, A.I.; Christofers, E.; Schröder, J.M.J.Exp. Med. 1992, 176, 587-92.
7. 6. Alam, R.; Stafford, S.; Forsythe, P.; Harrison, R.; Faubion, D., Lett-Brown, M.A.; Grant, J.A. J. Immunol. 1993, 150, 3442-7.
8. 7. Rot, A.; Krieger, M.; Brunner, T.; Bischoff, S.C.; Schall, T.J.; Dahinden, C.A. J. Exp. Med 1992, 176, 1489-95.
9. 8. Power, C.A.; Wells, N.C. Tips 1996, 17, 209-213.
10. 9. RT-PCR on THP-1 cells showed that CCR1 and CCR2 are the major chemokine receptors with very little CCR3 and no CCR4 expression. Dr. Ian Hayes personnal communication.
11. 10. Matthews, N,; Franklin, R.J.; Kendrick, D.A. Biochem. Pharmaco.1995, 50, 1053-1061.
12. 11. Takeda Chem. Ind. LTD (JP) 1997. Patent apllication no. WO 97/24325.
13. 125I MIP-1α binding by 29% @ 30μM.
14. 13. Jacob, R.M.; Régnier, G.L. Patent application FR 1,1799,68. CA; 55: 19964c. Blondel, J.C.R.; Fouche, J.C.C. Patent application DE 2235998. CA; 78: 97682v.
15. 13. Jacob, R.M.; Régnier, G.L. Patent application FR 1,1799,68. CA; 55: 19964c. Blondel, J.C.R.; Fouche, J.C.C. Patent application DE 2235998. CA; 78: 97682v.
16. 14. Craig P.N., Gordon, M.; Lafferty, J.J.; Lester, B.M.; Saggiono, A.J.; Zinkle, C.L J. Org. Chem. 1961, 26, 1138-1143 and references cited.
17. 15. Schmitt, J.; Boitard, J.; Comoy, P.; Hallot, A.; Suquet, M. Bull. Soc. Chem. Fr. 1957, 938-942. Massie, S.P.; Cooke, I.; Hills, W.A. J. Org. Chem. 1956, 21, 1006-1008 and references cited.
18. 15. Schmitt, J.; Boitard, J.; Comoy, P.; Hallot, A.; Suquet, M. Bull. Soc. Chem. Fr. 1957, 938-942. Massie, S.P.; Cooke, I.; Hills, W.A. J. Org. Chem. 1956, 21, 1006-1008 and references cited.